Trident Texofab Limited has completed its regulatory compliance requirements by submitting the mandatory Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The submission was made to BSE Limited on April 8, 2026, as part of the company's ongoing regulatory obligations.

Certificate Details and Compliance

The certificate was issued by KFin Technologies Limited, which serves as the company's Registrar and Share Transfer Agent. The document confirms that all required details of securities dematerialized and rematerialized during the quarter ended March 31, 2026, have been properly furnished to all stock exchanges where Trident Texofab's shares are listed.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 mandates that registrars and share transfer agents provide quarterly certificates confirming the proper reporting of dematerialization and rematerialization activities. This regulation ensures transparency in the securities market and maintains accurate records of share transfers between physical and electronic formats.

Company Information

Triden Texofab Limited operates under CIN L17120GJ2008PLC054976 and maintains its registered office in Surat, Gujarat. The company's shares are traded on BSE with scrip code 540726. The compliance certificate submission was signed by Rahul Jariwala, Company Secretary and Compliance Officer, demonstrating the company's commitment to maintaining proper corporate governance standards.

Depository Communications

KFin Technologies Limited issued separate certificates to both major depositories in India - Central Depository Services (India) Limited (CDSL) and National Securities Depository Limited (NSDL). These communications, dated April 1, 2026, confirm that all necessary details regarding securities transactions during the quarter have been appropriately reported to the respective stock exchanges.

This regulatory submission reflects Trident Texofab's adherence to SEBI's compliance framework and its commitment to maintaining transparency in securities transactions and record-keeping processes.

Trident Texofab Limited has announced the successful completion of a separate meeting of independent directors held on March 27, 2026, in accordance with regulatory compliance requirements. The meeting was conducted pursuant to Schedule IV of the Companies Act, 2013 and Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details and Venue

The independent directors' meeting took place at the company's office located at 2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Nodh 4/1650, Sahara Darwaja, Surat-395003, Gujarat. The meeting was efficiently conducted within a 25-minute timeframe, commencing at 05:00 p.m. and concluding at 05:25 p.m.

Key Agenda Items Discussed

The independent directors addressed three critical governance matters during their separate meeting:

Regulatory Compliance and Governance

The meeting demonstrates Trident Texofab Limited's commitment to maintaining strong corporate governance standards. The independent directors reviewed the performance of non-independent directors and evaluated the board's overall effectiveness. Additionally, they conducted a comprehensive assessment of the Chairman's performance, incorporating perspectives from both executive and non-executive directors.

Information Flow Evaluation

A significant focus of the meeting was assessing the quality, quantity, and timeliness of information flow between the company's management and the Board. This evaluation ensures that directors receive necessary information to effectively and reasonably perform their fiduciary duties.

Company Secretary Confirmation

Rahul Jariwala, Company Secretary and Compliance Officer (Membership No. A70164), digitally signed the disclosure document on March 27, 2026, confirming the meeting's completion and requesting the stock exchange to take the information on record. The company maintains its listing on BSE Limited under the stock ID TTFL with scrip code 540726.